Application of tissue-specific magnetic resonance imaging contrast agent gadolinium ethoxybenzyl dimeglumine on precision hepatic surgery
10.3760/cma.j.issn.1673-9752.2017.02.004
- VernacularTitle:钆塞酸二钠增强MRI检查在精准肝脏外科中的应用
- Author:
Kuansheng MA
;
Jiayun JIANG
- Keywords:
Liver diseases;
Precision hepatic surgery;
Gadolinium ethoxybenzyl dimeglumine;
Magetic resonance imaging
- From:
Chinese Journal of Digestive Surgery
2017;16(2):124-129
- CountryChina
- Language:Chinese
-
Abstract:
Gadolinium ethoxybenzyl dimeglumine (Gd-EOB-DTPA),a newly applicable hepatocyte-specific contrast agent,can provide both dynamic and hepatobiliary images and has been rapidly accepted by clinicians for the diagnosis of liver lesions and preoperative evaluation.Gd-EOB-DTPA can fulfill hepatic perfusion imaging,detection and characterization of focal liver lesions,evaluation of liver function,and predict biological behaviors of hepatocellular carcinoma (HCC) within the same examination in a relatively short time window.A large number of domestic and foreign studies have confirmed that hepatobiliaryspecific enhanced magnetic resonance imaging (MRI) was significantly superior to MRI scan,enhanced CT and ultrasound in diagnosing HCC.With the help of the advanced imaging techniques,surgeons can accurately diagnose and assess the situation of patients to implement individualized treatment plans,and therefore these will promote the development of precision hepatic surgery.
